ADVENZYMES

Advanced Enzyme Technologies Ltd.

NSE: ADVENZYMES

BSE: 540025

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Biotechnology

318.60-1.4 (-0.45%)

8 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

86.9 / 100

Value Score

62.8 / 100

Price Momentum Score

72.2 / 100

QVM Score

92.9 / 100

Key Metrics

Market Cap

3567.56

P/E (TTM)

21.15

P/B

2.19

P/S (TTM)

4.78

EV/EBITDA

12.62

CAPE (5Y)

27.07

ROE (TTM)

11.01

ROCE (TTM)

11.73

ROA (TTM)

9.75

Avg 3Y ROE

10.27

Earnings 3Y CAGR

16.87

Sales 3Y CAGR

11.32

Sales 5Y CAGR

8.24

Debt/Equity

0.02

Consensus TP

370.00

Strong Buy %

Promoter Holding

43.26

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Advanced Enzyme Technologies Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 21.14 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -67.57%

What is P/E Ratio?

Median: 65.18

Value 21.14

21.15306.41

Strong price momentum

Price Momentum score of 72.2 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

72.2 / 100

High and stable operating margin

The company reported strong operating margin of 25.34% for 12-month ended 31 Mar 2026 and operating margin improved marginally by 55 bps from 1 year ago

What is Operating profit margin?

Moderate revenue growth and above median growth of industry

The company delivered moderate revenue growth of 17.09% for 12-month ended 31 Mar 2026 and the growth was 2.82 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 14.27

Value 17.09

-78.3517.09

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 28.8% for 12-month ended 31 Mar 2026 and the growth was 60.11 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.02 as on 31 Mar 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 9 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Low dividend yield

The company has a low dividend yield of 0.38%

What is Dividend yield?

Neutral

Moderate and stable ROE

The company reported moderate ROE of 11.01% for 12-month ended 31 Mar 2026 and ROE improved marginally by 150 bps from 1 year ago

What is ROE (FY)?

Company's earnings are of moderate quality

Earnings quality score of 61.8 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

61.8 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Advanced Enzyme Technologies Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Advanced Enzyme Technologies Ltd. Shareholding Pattern

Quarterly breakdown of Advanced Enzyme Technologies Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	57.88	58.13	55.45	55.39	55.38	52.30	52.55	52.71	52.70	52.70	49.87	49.87	49.87	46.52	45.92	43.62	43.49	43.02	42.95	42.93	43.08	43.08	43.07	43.04	43.26
Indian Promoter	17.35	17.42	14.73	14.70	14.68	11.62	11.87	12.15	12.15	12.15	9.33	9.33	9.33	5.45	4.85	2.55	2.42	1.95	1.98	1.97	1.97	1.97	1.97	1.95	1.95
Foreign Promoter	40.53	40.71	40.71	40.70	40.69	40.68	40.68	40.56	40.56	40.55	40.55	40.55	40.55	41.07	41.07	41.07	41.07	41.07	40.97	40.95	41.11	41.11	41.11	41.09	41.31
Institutions	20.01	19.71	22.33	23.39	24.11	24.86	24.93	25.38	24.91	24.98	27.28	27.38	27.59	29.48	28.75	29.52	30.57	20.11	20.65	20.75	20.09	31.91	31.82	31.37	30.90
Mutual Funds / UTI	8.78	8.59	6.26	6.24	7.29	8.23	8.32	8.50	6.46	6.05	5.36	5.25	5.29	7.08	5.84	5.42	5.50	5.82	5.57	5.57	5.36	5.46	3.24	2.16	1.93
FI/Bank/Insurance	0.11	0.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	11.12	11.02	16.01	17.11	16.79	16.40	16.27	16.39	18.01	18.72	21.68	21.74	21.86	21.89	22.27	22.54	23.01	12.03	12.63	12.58	11.90	23.45	25.41	25.85	25.50
Other Institutions	0.00	0.04	0.06	0.04	0.04	0.23	0.35	0.49	0.45	0.21	0.24	0.39	0.44	0.50	0.65	1.56	2.06	2.26	2.45	2.60	2.83	2.99	3.17	3.35	3.48
Non-Institution	22.11	22.16	22.23	21.22	20.50	22.84	22.52	21.91	22.38	22.32	22.85	22.75	22.54	24.00	25.33	26.87	25.94	36.88	36.41	36.32	36.83	25.02	25.10	25.60	25.84
Bodies Corporate	1.03	1.00	0.54	2.64	2.65	2.72	2.60	2.60	2.63	2.71	0.75	0.66	0.59	1.07	0.79	1.08	0.96	1.03	1.32	1.28	1.29	1.40	1.18	1.23	1.18
Others (incl. Retail) No. of shareholders	21.08 52,782	21.16 55,454	21.69 59,728	18.58 64,836	17.85 62,072	20.12 78,917	19.92 86,735	19.31 83,998	19.75 86,228	19.61 84,046	22.10 83,931	22.09 80,865	21.95 77,216	22.93 74,728	24.54 72,276	25.79 72,621	24.98 68,232	35.85 64,805	35.09 66,215	35.04 66,848	35.54 64,883	23.62 67,149	23.92 69,245	24.37 67,649	24.66 65,814

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Biotech	2.66%	11 / 15
2	Nifty Microcap 250	0.21%	192 / 250
3	Nifty Total Market	0.01%	678 / 749

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Advanced Enzyme Technologies Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Vasant Rathi Promoter & Director	March-2026	Market Purchase (Acquisition) 13th Mar 2026	26.67 %	₹ 298.45	18.00 k	₹ 53.72 lac
Vasant Rathi Promoter & Director	March-2026	Market Purchase (Acquisition) 10th Mar 2026	26.61 %	₹ 293.60	65.00 k	₹ 1.91 cr
Vasant Rathi Promoter & Director	March-2026	Market Purchase (Acquisition) 10th Mar 2026	26.55 %	₹ 295.38	20.00 k	₹ 59.08 lac
Vasant Rathi Promoter & Director	March-2026	Market Purchase (Acquisition) 10th Mar 2026	26.57 %	₹ 297.67	55.00 k	₹ 1.64 cr
Vasant Rathi Promoter & Director	February-2026	Market Purchase (Acquisition) 9th Feb 2026	26.53 %	₹ 291.12	20.00 k	₹ 58.22 lac
Vasant Rathi Promoter & Director	February-2026	Market Purchase (Acquisition) 7th Feb 2026	26.50 %	₹ 288.19	37.30 k	₹ 1.08 cr
Vasant Rathi Promoter & Director	February-2026	Market Purchase (Acquisition) 6th Feb 2026	26.47 %	₹ 286.18	21.33 k	₹ 61.05 lac
Vasant Rathi Promoter & Director	February-2026	Market Purchase (Acquisition) 6th Feb 2026	26.49 %	₹ 287.60	11.36 k	₹ 32.68 lac
Leela Kishor Rathi Immediate Relative	September-2025	Market Sale (Disposal) 25th Sep 2025	0.12 %	₹ 338.00	3.00 k	₹ 10.14 lac
Leela Kishor Rathi Immediate Relative	September-2025	Market Sale (Disposal) 25th Sep 2025	0.13 %	₹ 338.01	14.16 k	₹ 47.86 lac

…

Corporate Actions

History of Advanced Enzyme Technologies Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 1.35/share
Record date: 24th Jul 2026Ex-date: 24th Jul 2026
Announced on: 10th May 2026
Dividend₹ 1.20/share
Record date: 23rd Jul 2025Ex-date: 23rd Jul 2025
Announced on: 13th May 2025
Dividend₹ 4/share
Record date: 17th May 2025Ex-date: 16th May 2025
Announced on: 10th Nov 2024
Dividend₹ 1.10/share
Record date: 18th Jul 2024Ex-date: 18th Jul 2024
Announced on: 11th May 2024
Dividend₹ 4/share
Record date: 18th May 2024Ex-date: 17th May 2024
Announced on: 4th May 2024

Company Profile

Overview of Advanced Enzyme Technologies Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Advanced Enzyme Technologies Limited is an India-based company engaged in the manufacturing of enzymes and probiotics. It is focused on the research and development, manufacturing, and marketing of approximately 400 products, developed from over 68 enzymes and probiotics. It operates in a business s...

Key personnel

Mr. Beni Prasad Rauka

Chief Financial Officer

Ms. Martina Doering

Managing Director and Head Of Business Development, Evoxx Technologies GmbH, Germany

Mr. Harshad Doshi

Chief Financial Officer and Chief Operating Officer of the US Subsidiaries

Dr. Michael Puls

Managing Director and Head Of Research and Development, Evoxx Technologies GmbH, Germany

Mr. Sanjay Prakash Basantani

Company Secretary and Head Legal

Mr. Ronak Saraf

Investor Relations Manager

Mr. Ronak Saraf

Investor Relations Manager

Mr. Vasant Laxminaray RathiD

Non-Executive Chairman of the Board

View all

Incorporated on

15 Mar 1989

Last Annual

Last Interim

31 Mar 2026

No. of Employees

IPO date

01 Aug 2016

Free Float

3,63,63,872

Website

https://www.advancedenzymes.com/

Phone no.

+912241703200

Address

SUN MAGNECTICA, 5TH FLOOR, NEAR LIC SERVICE ROAD, LOUISWADI, , 400604, India

Frequently Asked Questions

What is the current share price of Advanced Enzyme Technologies Ltd.?

The current share price of Advanced Enzyme Technologies Ltd. is ₹ 318.60 as of 8 Jul 2026.

What is the market capitalisation of Advanced Enzyme Technologies Ltd.?

The market capitalisation of Advanced Enzyme Technologies Ltd. stands at ₹ 3,567.56 Cr.

What is the PE ratio of Advanced Enzyme Technologies Ltd.?

The Price-to-Earnings (PE) ratio of Advanced Enzyme Technologies Ltd. is 21.15 as of the latest trailing twelve months data.

What is the ROE and ROCE of Advanced Enzyme Technologies Ltd.?

Advanced Enzyme Technologies Ltd. has a Return on Equity (ROE) of 11.01% and a Return on Capital Employed (ROCE) of 11.73% as per the latest financial reports.

What is the 52-week high and low of Advanced Enzyme Technologies Ltd.?

The 52-week high of Advanced Enzyme Technologies Ltd. is - and the 52-week low is -.

What is the dividend yield of Advanced Enzyme Technologies Ltd.?

The dividend yield of Advanced Enzyme Technologies Ltd. is 0.38% based on the current market price.

What is the FII and DII holding in Advanced Enzyme Technologies Ltd.?

Foreign Institutional Investors (FII) hold 25.50%, Domestic Institutional Investors (DII) hold 1.93% and retail/public investors hold 24.66% of Advanced Enzyme Technologies Ltd. shares.

What sector does Advanced Enzyme Technologies Ltd. belong to?

Advanced Enzyme Technologies Ltd. operates in the Healthcare sector.

What is the beta of Advanced Enzyme Technologies Ltd.?

The beta of Advanced Enzyme Technologies Ltd. is 0.95, indicating its price volatility relative to the broader market. Over the past 1 year, Advanced Enzyme Technologies Ltd. has delivered an absolute return of -0.90%.

What is the RSI of Advanced Enzyme Technologies Ltd.?

The 14-day Relative Strength Index (RSI) of Advanced Enzyme Technologies Ltd. is 34.36, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Advanced Enzyme Technologies Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Advanced Enzyme Technologies Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Holdings and Presence

Stock Analysis

Corporate Actions

Company Profile